Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
10/2001
10/02/2001US6297270 Process for the preparation of 2,3-Dihydroindoles (indolines), novel 2,3-dihydroindoles, and their use
10/02/2001US6297269 Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
10/02/2001US6297260 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
09/2001
09/27/2001WO2001071430A1 Organophotoreceptors for electrophotography comprising hydrazone charge transport compounds
09/27/2001WO2001070743A1 Non-amidine containing protease inhibitors
09/27/2001WO2001070693A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors
09/27/2001WO2001070686A1 5-hydroxy indole derivatives for treating glaucoma
09/27/2001WO2001070675A2 Inhibitors of histone deacetylase
09/27/2001WO2001070364A1 Sublimation purifying method and apparatus
09/27/2001WO2001070230A2 Compounds with 5-ht activity useful for controlling visual field loss
09/27/2001WO2001070223A1 Compounds with 5-ht2 and 5-ht1a agonist activity for treating glaucoma
09/27/2001WO2001070222A2 Compounds with 5-ht1a activity useful for treating disorders of the outer retina
09/27/2001WO2001062705A8 Aminoalcohol derivatives
09/27/2001WO2001060822A8 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
09/27/2001WO2001019794A3 Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents
09/27/2001WO2001017972A3 Novel herbicides
09/27/2001WO2000061537A3 Pharmaceutical compounds
09/27/2001US20010025105 Anticancer agent; Alzheimer's therapy
09/27/2001CA2404002A1 Inhibitors of histone deacetylase
09/27/2001CA2402516A1 Non-amidine containing protease inhibitors
09/27/2001CA2401728A1 Difluorobutyric acid metalloprotease inhibitors
09/27/2001CA2400637A1 Compounds with 5-ht2 and 5-ht1a agonist activity for treating glaucoma
09/27/2001CA2399985A1 Compounds with 5-ht activity useful for controlling visual field loss
09/26/2001EP1136474A1 1-Acetyl-5-bromo-4,6-dimethyl-indoline
09/26/2001EP1136071A2 Use of glycogen phosphorylase inhibitors
09/26/2001EP1135393A2 Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers
09/26/2001EP1135381A1 Eletriptan hydrobromide monohydrate
09/26/2001EP1135378A1 Benzamide derivatives and their use as apob-100 secretion inhibitors
09/26/2001EP1135132A2 Inhibitors of multidrug transporters
09/26/2001EP1135124A2 Antihypertriglyceridemic, antihyperglycemic, anti-angiogenic and wound healing substituded indolealkanoic acids
09/26/2001EP1135123A1 Use of isatin derivatives as ion channel activating agents
09/26/2001EP0934252B1 Amide derivatives and their use as pesticides
09/26/2001CN1071738C Carboxylic derivatives exhibiting phospholipase A2 inhibitory activity
09/25/2001US6294674 Dibenzofuran sulfonamide matrix metalloproteinase inhibitors
09/25/2001US6294504 Antidotes for herbicides
09/25/2001CA2213404C Use of angiogenesis suppressors for inhibiting hair growth
09/25/2001CA1341296C 2-azabicycloalkane-3-carboxylic acid derivatives, processes for their preparation, agents containing these compounds and their use
09/22/2001CA2341344A1 Use of glycogen phosphorylase inhibitors
09/20/2001WO2001068619A1 5-amide substituted diarylamines as mex inhibitors
09/20/2001WO2001068603A2 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl iv, processes for their preparation, and their use
09/20/2001WO2001068599A2 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form
09/20/2001WO2001068593A2 Amino acid derivatives as hiv aspartyl protease inhibitors
09/20/2001WO2001068591A1 Carboxylic acid derivatives as ip antagonists
09/20/2001WO2001068585A1 Novel amide compounds
09/20/2001WO2001068055A1 Pharmaceutical compositions of glycogen phosphorylase inhibitors
09/20/2001WO2000027378A3 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases
09/20/2001US20010023294 New process for the preparation of isoindoline
09/20/2001EP1143960A3 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases
09/20/2001CA2403241A1 Pharmaceutical compositions of glycogen phosphorylase inhibitors
09/20/2001CA2403017A1 5-amide substituted diarylamines as mex inhibitors
09/20/2001CA2402746A1 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form
09/20/2001CA2401821A1 Amino acid derivatives as hiv aspartyl protease inhibitors
09/19/2001EP1134213A2 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides
09/19/2001EP1133293A1 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
09/19/2001EP0923529B1 Substitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
09/19/2001EP0874849B1 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives
09/19/2001EP0612244B1 Endothelin receptor antagonists
09/19/2001CN1313853A Oxindole derivatives as growth hormone releasers
09/19/2001CN1313846A C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cystenine proteases
09/19/2001CN1313286A S type 4-substituted hydroxypyranoindolidine compound and its derivatives and preparation thereof
09/18/2001US6291683 N-arloxyethyl-alkylamines for the treatment of depression
09/18/2001US6291679 Process for preparing benzoperhydroisoindole compounds
09/18/2001US6291508 Potent ability to bind to retinoic acid receptors thus useful in treating psoriasis and rheumatoid arthritis.
09/18/2001US6291507 Chemical compounds
09/18/2001US6291464 Aminopiperazine derivatives
09/18/2001US6291451 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
09/18/2001US6291413 O-substituted N,N-diacylhydroxylamine bleach activators and compositions employing the same
09/18/2001US6291400 Herbicidal compounds
09/13/2001WO2001066520A1 Indole derivatives, process for preparation of the same and use thereof
09/13/2001WO2001066153A1 Fluorescent membrane intercalating probes and methods for their use
09/13/2001WO2001066142A1 Preparations for chondrogenesis
09/13/2001WO2000059883A3 Method for producing n-aryl-aza-heterocycles in the presence of cesium carbonate
09/13/2001US20010021779 Acetonitrile eluent
09/13/2001US20010021777 Indane or dihydroindole derivatives
09/13/2001US20010021775 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor Xa
09/13/2001US20010021719 2-phenyl-1- [4- (2-aminoethoxy) - benzyl] - indoles as estrogenic agents
09/13/2001CA2402174A1 Indole derivatives, process for preparation of the same and use thereof
09/12/2001EP1132380A1 E-Isomeric fullerene derivatives
09/12/2001EP1132379A1 Novel thiol derivatives, process for producing the same and utilization thereof
09/12/2001EP1132087A1 Remedies for polycystic ovary syndrome
09/12/2001EP1131321A2 Indole derivatives and their use as serotonin receptor ligands
09/12/2001EP1131308A1 New piperazine and piperidine compounds
09/12/2001EP1131301A1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof
09/12/2001EP1131060A2 Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an hmg coa reductase inhibitor
09/12/2001EP1032424B1 Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor
09/12/2001EP0832066B1 Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
09/12/2001CN1312812A Muscarinic agonists and antagonists
09/12/2001CN1312802A Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
09/12/2001CN1312718A Selective estrogen receptor modulator in combination with sex steriod precursors and the like
09/12/2001CN1312249A Preparation of asymmetric cyanine dyes for DVD-R CD
09/11/2001US6288123 Therapeutic guanidines
09/11/2001US6288120 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
09/11/2001US6288104 Administering seretonin uptake inhibitors to treat depression, psychological and psychiatric disorders with an anxiety component, alcohol and drug dependence, bulimia nervosa and obsessive-compulsive disorders
09/11/2001US6288103 Monocyte chemoattractant proteins antagonist such as n-(3-chlorophenylsulphonyl)indole-2-carboxylic acid; antiinflammatory agents
09/11/2001US6288086 N-hydroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
09/11/2001US6288077 2,3-methano-amino acid compounds
09/11/2001US6288063 Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
09/11/2001US6288055 Analgesic agents
09/11/2001CA2087091C Excitatory amino acid antagonists
09/11/2001CA2037099C Crystalline salt of 4-(di-n-propyl) amino-6-aminocarbonyl-1,3,4,5-tetrahydrobenz ¢cd! indole